|
1
|
Klimstra DS, Modlin IR, Coppola D, Lloyd
RV and Suster S: The pathologic classification of neuroendocrine
tumors: A review of nomenclature, grading, and staging systems.
Pancreas. 39:707–712. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fischer L, Kleeff J, Esposito I, Hinz U,
Zimmermann A, Friess H and Büchler MW: Clinical outcome and
long-term survival in 118 consecutive patients with neuroendocrine
tumours of the pancreas. Br J Surg. 95:627–635. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Niederle MB, Hackl M, Kaserer K and
Niederle B: Gastroenteropancreatic neuroendocrine tumours: The
current incidence and staging based on the WHO and European
Neuroendocrine Tumour Society classification: An analysis based on
prospectively collected parameters. Endocr Relat Cancer.
17:909–918. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bilimoria KY, Talamonti MS, Tomlinson JS,
Stewart AK, Winchester DP, Ko CY and Bentrem DJ: Prognostic score
predicting survival after resection of pancreatic neuroendocrine
tumors: Analysis of 3851 patients. Ann Surg. 247:490–500. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hauso O, Gustafsson BI, Kidd M, Waldum HL,
Drozdov I, Chan AK and Modlin IM: Neuroendocrine tumor
epidemiology: Contrasting Norway and North America. Cancer.
113:2655–2664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang M, Zeng L, Zhang Y, Su AP, Yue PJ and
Tian BL: Surgical treatment and clinical outcome of nonfunctional
pancreatic neuroendocrine tumors: A 14-year experience from one
single center. Medicine (Baltimore). 93:e942014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Centonze DC, Cinardi N and Giannone G:
Surgical resection for neuroendocrine tumors of the pancreas: A
fourteen years single institutional observation. Eur Rev Med
Pharmacol Sci. 18:(Suppl 2). 32–35. 2014.PubMed/NCBI
|
|
8
|
Wang SE, Su CH, Kuo YJ, Shyr YM, Li AF,
Chen TH, Wu CW and Lee CH: Comparison of functional and
nonfunctional neuroendocrine tumors in the pancreas and
peripancreatic region. Pancreas. 40:253–259. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Casadei R, Ricci C, Pezzilli R, Campana D,
Tomassetti P, Calculli L, Santini D, Antonacci N and Minni F: Value
of both WHO and TNM classification systems for patients with
pancreatic endocrine tumors: Results of a single-center series.
World J Surg. 33:2458–2463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Casadei R, Ricci C, Rega D, D'Ambra M,
Pezzilli R, Campana D, Nori F, Minni F and Tomassetti P: Pancreatic
endocrine tumors less than 4 cm in diameter: Resect or enucleate? A
single-center experience. Pancreas. 39:825–828. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Franko J, Feng W, Yip L, Genovese E and
Moser AJ: Non-functional neuroendocrine carcinoma of the pancreas:
Incidence, tumor biology, and outcomes in 2,158 patients. J
Gastrointest Surg. 14:541–548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Casadei R, Ricci C, Pezzilli R, Campana D,
Tomassetti P, Calculli L, Santini D, D'Ambra M and Minni F: Are
there prognostic factors related to recurrence in pancreatic
endocrine tumors? Pancreatology. 10:33–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang M, Zeng L, Zhang Y, Wang WG, Wang L,
Ke NW, Liu XB and Tian BL: TNM staging of pancreatic neuroendocrine
tumors: An observational analysis and comparison by both AJCC and
ENETS systems from 1 single institution. Medicine (Baltimore).
94:e6602015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Partelli S, Inama M, Rinke A, Begum N,
Valente R, Fendrich V, Tamburrino D, Keck T, Caplin ME, Bartsch D,
et al: Long-term outcomes of surgical management of pancreatic
neuroendocrine tumors with synchronous liver metastases.
Neuroendocrinology. 102:68–76. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rindi G, Klöppel G, Alhman H, Caplin M,
Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M,
Komminoth P, et al: TNM staging of foregut (neuro)endocrine tumors:
A consensus proposal including a grading system. Virchows Arch.
449:395–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim SJ, Kim JW, Oh DY, Han SW, Lee SH, Kim
DW, Im SA, Kim TY, Heo DS and Bang YJ: Clinical course of
neuroendocrine tumors with different origins (the pancreas,
gastrointestinal tract, and lung). Am J Clin Oncol. 35:549–556.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Strosberg JR, Cheema A, Weber JM, Ghayouri
M, Han G, Hodul PJ and Kvols LK: Relapse-free survival in patients
with nonmetastatic, surgically resected pancreatic neuroendocrine
tumors: An analysis of the AJCC and ENETS staging classifications.
Ann Surg. 256:321–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Strosberg JR, Cheema A, Weber J, Han G,
Coppola D and Kvols LK: Prognostic validity of a novel American
Joint Committee on Cancer Staging Classification for pancreatic
neuroendocrine tumors. J Clin Oncol. 29:3044–3049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yao JC, Hassan M, Phan A, Dagohoy C, Leary
C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A and Evans
DB: One hundred years after ‘carcinoid’: Epidemiology of and
prognostic factors for neuroendocrine tumors in 35,825 cases in the
United States. J Clin Oncol. 26:3063–72. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Strosberg J, Gardner N and Kvols L:
Survival and prognostic factor analysis of 146 metastatic
neuroendocrine tumors of the mid-gut. Neuroendocrinology.
89:471–476. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Casadei R, Ricci C, Tomassetti P, Campana
D and Minni F: Factors related to long-term survival in patients
affected by well-differentiated endocrine tumors of the pancreas.
ISRN Surg. 2012:3893852012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rindi G, Falconi M, Klersy C, Albarello L,
Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A,
Doglioni C, et al: TNM staging of neoplasms of the endocrine
pancreas: Results from a large international cohort study. J Natl
Cancer Inst. 104:764–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bettini R, Boninsegna L, Mantovani W,
Capelli P, Bassi C, Pederzoli P, Fave GF Delle, Panzuto F, Scarpa A
and Falconi M: Prognostic factors at diagnosis and value of WHO
classification in a mono-institutional series of 180
non-functioning pancreatic endocrine tumours. Ann Oncol.
19:903–908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Scarpa A, Mantovani W, Capelli P, Beghelli
S, Boninsegna L, Bettini R, Panzuto F, Pederzoli P, Fave G delle
and Falconi M: Pancreatic endocrine tumors: Improved TNM staging
and histopathological grading permit a clinically efficient
prognostic stratification of patients. Mod Pathol. 23:824–833.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ito H, Abramson M, Ito K, Swanson E, Cho
N, Ruan DT, Swanson RS and Whang EE: Surgery and staging of
pancreatic neuroendocrine tumors: A 14-year experience. J
Gastrointest Surg. 14:891–898. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bahra M, Jacob D, Pascher A, Plockinger U,
Kristiansen G, Neuhaus P and Langrehr JM: Surgical strategies and
predictors of outcome for malignant neuroendocrine tumors of the
pancreas. J Gastroenterol Hepatol. 22:930–935. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cherenfant J, Talamonti MS, Hall CR,
Thurow TA, Gage MK, Stocker SJ, Lapin B, Wang E, Silverstein JC,
Mangold K, et al: Comparison of tumor markers for predicting
outcomes after resection of nonfunctioning pancreatic
neuroendocrine tumors. Surgery. 156:1504–1511. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu TC, Hamilton N, Hawkins W, Gao F and
Cao D: Comparison of WHO Classifications (2004, 2010), the Hochwald
grading system, and AJCC and ENETS staging systems in predicting
prognosis in locoregional well-differentiated pancreatic
neuroendocrine tumors. Am J Surg Pathol. 37:853–859. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferrone CR, Tang LH, Tomlinson J, Gonen M,
Hochwald SN, Brennan MF, Klimstra DS and Allen PJ: Determining
prognosis in patients with pancreatic endocrine neoplasms: Can the
WHO classification system be simplified? J Clin Oncol.
25:5609–5615. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
La Rosa S, Rigoli E, Uccella S, Novario R
and Capella C: Prognostic and biological significance of
cytokeratin 19 in pancreatic endocrine tumours. Histopathology.
50:597–606. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheema A, Weber J and Strosberg JR:
Incidental detection of pancreatic neuroendocrine tumors: An
analysis of incidence and outcomes. Ann Surg Oncol. 19:2932–2936.
2012. View Article : Google Scholar : PubMed/NCBI
|
